News & Events NewsPress Releases In the Code Blog In the News Media Kit Press Releases May 19, 2023 Encoded Therapeutics Addresses Common Source of Gene Therapy Toxicity While Achieving Precise Brain Expression in Non-Human Primates, Presented at the American Society of Gene and Cell Therapy 26th Annual Meeting May 18, 2022 Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at the American Society of Gene and Cell Therapy 25th Annual Meeting May 02, 2022 Encoded Therapeutics to Present Nonclinical Data Showing Targeted Brain Expression While De-Targeting the Liver With Genomic Medicine Platform at the American Society of Gene and Cell Therapy 25th Annual Meeting View All Press Releases In the Code Blog October 24, 2023 Our platform to discover and validate regulatory elements to drive targeted transgene expression for use in gene therapies Read Full Article October 13, 2022 Building Customized Gene Expression Profiles Read Full Article September 20, 2022 Right-Sized in RTP: Building Out Encoded’s Manufacturing Ecosystem Read Full Article View All Blog Articles In the News June 13, 2022 Gene therapy targets interneurons to tackle Dravet syndrome Spectrum May 12, 2022 Gene Therapy’s Commercial Manufacturing Issues — With Encoded Therapeutics’ Andy Stober Cell and Gene Podcast August 10, 2021 Activating SCN1A to Treat Dravet Syndrome GeneTherapyLive View All News Stories Media Kit Logo Leadership Photos Kartik Ramamoorthi, Ph.D. Encoded Co-Founder, CEO and Board Member Stephanie Tagliatela Encoded Co-Founder, Chief Scientific Officer and Board Member Salvador Rico, M.D., Ph.D. Encoded Chief Medical Officer Photos Encoded lab coat Encoded Therapeutics headquarters in South San Francisco Scientists in Encoded’s sequencing lab Scientist in Encoded’s lab Scientist in Encoded’s lab Scientist in Encoded’s lab Download Photo Archive Video Footage